Aileron Therapeutics, Inc. (ALRN)

Trade ALRN now with
12/21/2020 8:12:10 AM Aileron Therapeutics Provides Business Update And Outlines Strategic Priorities For 2021
6/1/2020 7:20:26 AM Aileron Therapeutics Reports Positive Interim Data From Phase 1b/2 Clinical Trial Of ALRN-6924
12/18/2019 8:44:59 AM Aileron Therapeutics Promotes Richard Wanstall To CFO And Treasurer
9/9/2019 8:19:11 AM Aileron Therapeutics CFO Don Dougherty To Leave
6/24/2019 8:11:07 AM Aileron Therapeutics Elects William McKee And Josef Von Rickenbach To Board
12/4/2018 9:17:27 AM Aileron Presents Interim ALRN-6924 Data From PTCL, MDS, And AML Clinical Trials
11/27/2018 8:11:12 AM Aileron Enters Clinical Trial Collaboration With Pfizer To Evaluate ALRN-6924 Plus IBRANCE In MDM2-Amplified Cancers
11/5/2018 4:11:03 PM Aileron Therapeutics Appoints Vojislav Vukovic As Chief Medical Officer